Celltrion

Vegzelma

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Celltrion

Vegzelma HCPCS:

Q5129

HCPCS Code Descriptor:

Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg

Category:

Q Code

Vegzelma NDCs:

72606-0012-01, 72606-0011-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Vegzelma CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

72606-0011-01, 72606-0012-01

About Vegzelma:

Vegzelma is an Oncology drug manufactured by Celltrion and administered via the Intravenous route of administration. The Q Code: Q5129 is aligned to the drug Vegzelma.

Vegzelma is an artificial antibody called IgG1 that is used to treat a variety of cancers. This medication works by blocking the VEGF protein in order to slow tumor growth. Vegzelma is manufactured by Celltrion USA and is biosimilar to the medication Avastin (J9035). Vegzelma is aligned to the HCPCS code Q5129, this code was aligned to the drug as of April 2023.

ACCESS PRICING AND MORE BY REGISTERING

Q5129 Added Date:

April 1, 2023

Q5129 Effective Date:

April 1, 2023

Q5129 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vegzelma billing and coding information.
Vegzelma patient assistance information can be found through Celltrion Connect at the URL: https://www.vegzelma.com/Vegzelma%20patient%20support%20program.pdf
Vegzelma prescribing information can be found at the link below:
Information regarding Vegzelma’s side effects can be found at MedlinePlus